These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35999270)
1. Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature. Yamada Y; Bohnenberger H; Kriegsmann M; Kriegsmann K; Sinn P; Goto N; Nakanishi Y; Seno H; Chigusa Y; Fujimoto M; Minamiguchi S; Haga H; Simon R; Sauter G; Ströbel P; Marx A Br J Cancer; 2022 Nov; 127(10):1876-1885. PubMed ID: 35999270 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities. Yamada Y; Belharazem-Vitacolonnna D; Bohnenberger H; Weiß C; Matsui N; Kriegsmann M; Kriegsmann K; Sinn P; Simon-Keller K; Hamilton G; Graeter T; Preissler G; Ott G; Schölch S; Nakajima N; Yoshizawa A; Haga H; Date H; Thomas RK; Petrini I; Giaccone G; Ströbel P; Marx A Cell Death Dis; 2022 Nov; 13(11):979. PubMed ID: 36402755 [TBL] [Abstract][Full Text] [Related]
3. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9. Yamada Y; Simon R; Iwane K; Nakanishi Y; Takeuchi Y; Yoshizawa A; Takada M; Toi M; Haga H; Marx A; Sauter G BMC Cancer; 2023 May; 23(1):438. PubMed ID: 37179317 [TBL] [Abstract][Full Text] [Related]
4. A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer Histotypes. Yamada Y; Simon-Keller K; Belharazem-Vitacolonnna D; Bohnenberger H; Kriegsmann M; Kriegsmann K; Hamilton G; Graeter T; Preissler G; Ott G; Roessner ED; Dahmen I; Thomas RK; Ströbel P; Marx A J Thorac Oncol; 2021 Jun; 16(6):1003-1016. PubMed ID: 33609752 [TBL] [Abstract][Full Text] [Related]
5. Expression of POU2F3 Transcription Factor and POU2AF2, POU2F3 Coactivator, in Tuft Cell-like Carcinoma and Other Tumors. Kaczorowski M; Ylaya K; Chłopek M; Lasota J; Miettinen M Am J Surg Pathol; 2025 Jan; 49(1):62-72. PubMed ID: 39319626 [TBL] [Abstract][Full Text] [Related]
6. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma. Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891 [TBL] [Abstract][Full Text] [Related]
7. POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma. Yamada Y; Sugimoto A; Hoki M; Yoshizawa A; Hamaji M; Date H; Haga H; Marx A Virchows Arch; 2022 Apr; 480(4):843-851. PubMed ID: 34988657 [TBL] [Abstract][Full Text] [Related]
8. Human airway tuft cells influence the mucociliary clearance through cholinergic signalling. Hollenhorst MI; Husnik T; Zylka M; Duda N; Flockerzi V; Tschernig T; Maxeiner S; Krasteva-Christ G Respir Res; 2023 Nov; 24(1):267. PubMed ID: 37925434 [TBL] [Abstract][Full Text] [Related]
9. Advillin is a tuft cell marker in the mouse alimentary tract. Ruppert AL; Keshavarz M; Winterberg S; Oberwinkler J; Kummer W; Schütz B J Mol Histol; 2020 Aug; 51(4):421-435. PubMed ID: 32617896 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor. Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y Front Oncol; 2021; 11():708735. PubMed ID: 34778027 [TBL] [Abstract][Full Text] [Related]
11. The critical roles and therapeutic implications of tuft cells in cancer. Li L; Ma M; Duan T; Sui X Front Pharmacol; 2022; 13():1047188. PubMed ID: 36569325 [TBL] [Abstract][Full Text] [Related]
12. OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage. Wu XS; He XY; Ipsaro JJ; Huang YH; Preall JB; Ng D; Shue YT; Sage J; Egeblad M; Joshua-Tor L; Vakoc CR Nature; 2022 Jul; 607(7917):169-175. PubMed ID: 35576971 [TBL] [Abstract][Full Text] [Related]
13. Sirt6-mediated epigenetic modification of DNA accessibility is essential for Pou2f3-induced thymic tuft cell development. Zhang Q; Zhang J; Lei T; Liang Z; Dong X; Sun L; Zhao Y Commun Biol; 2022 Jun; 5(1):544. PubMed ID: 35668088 [TBL] [Abstract][Full Text] [Related]
14. Gastric tuft cells express DCLK1 and are expanded in hyperplasia. Saqui-Salces M; Keeley TM; Grosse AS; Qiao XT; El-Zaatari M; Gumucio DL; Samuelson LC; Merchant JL Histochem Cell Biol; 2011 Aug; 136(2):191-204. PubMed ID: 21688022 [TBL] [Abstract][Full Text] [Related]
15. Appearance of tuft cells during prostate cancer progression. Vlajic K; Pennington Kluger H; Bie W; Merrill BJ; Nonn L; Kajdacsy-Balla A; Tyner AL Oncogene; 2023 Jul; 42(31):2374-2385. PubMed ID: 37386128 [TBL] [Abstract][Full Text] [Related]
16. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin. Zarka TA; Han AC; Edelson MI; Rosenblum NG Int J Gynecol Cancer; 2003; 13(2):240-3. PubMed ID: 12657131 [TBL] [Abstract][Full Text] [Related]
17. Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice. Yamashita J; Ohmoto M; Yamaguchi T; Matsumoto I; Hirota J PLoS One; 2017; 12(12):e0189340. PubMed ID: 29216297 [TBL] [Abstract][Full Text] [Related]